Adagene_Logo_GNW.png
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 07, 2024 10:01 ET | Adagene Inc.
- Improved safety and efficacy profiles for ADG126 versus ipilimumab driven by precision masking, novel epitope-dependent antibody-dependent cellular cytotoxicity (ADCC) and partial CTLA-4 blockade - ...
Acrow Provides Safe,
Acrow Provides Safe, Reliable Detour Solution During Bridge Replacement Project in Italy
November 07, 2024 10:00 ET | Acrow Bridge
PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Acrow, a leading international bridge engineering and supply company, noted today one of its modular steel bridges has been installed to carry...
22157.jpg
Turkey Steel Industry Research Report 2024: $21.05 Bn Market Trends, Regional Insights, Competition, Forecasts and Opportunities, 2019-2029F
November 07, 2024 10:00 ET | Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Turkey Steel Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.Turkey...
amero.png
Amero Revolutionizes Financial Access Across Latin America with Breakthrough Cross-Border Solutions
November 07, 2024 10:00 ET | Amero Exchange
Queensway, Gibraltar, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Amero, co-founded by Rafael Osiris Rodriguez (CEO), Nelson Peña (CFO), and Samuel Peralta (CTO), is pioneering a new era of accessible finance...
Gardners Candies Logo.jpg
It’s Peanut Butter Lovers Month! Enter to Win a Year of new Gardners Candies Peanut Butter Meltaway Grahams
November 07, 2024 10:00 ET | Gardners Candies
November is Peanut Butter Lovers Month. Gardners Candies is giving away a year's worth of new Original Peanut Butter Meltaway Grahams to five winners.
Logo.png
IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting
November 07, 2024 10:00 ET | Imunon, Inc.
IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was...
bolt_logo.png
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
November 07, 2024 10:00 ET | Bolt Biotherapeutics, Inc.
BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from...
IO Biotech.jpg
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
November 07, 2024 10:00 ET | IO Biotech
-- Metastatic non-small cell lung cancer (NSCLC) patients treated in the first line setting with IO102-IO103 in combination with Keytruda® demonstrated promising activity with an overall response rate...
Westland_Logos_Hor-Colour.png
Westland Insurance acquires P&C brokerage MSP Insurance
November 07, 2024 10:00 ET | Westland Insurance Group Ltd.
Surrey, BC/Territories of the Coast Salish (Kwantlen, Katzie, Semiahmoo, Tsawwassen First Nations), Nov. 07, 2024 (GLOBE NEWSWIRE) -- Westland Insurance today announced that it acquired MSP...
Almost 90% of Metro
Almost 90% of Metro Areas Posted Home Price Increases in Third Quarter of 2024
November 07, 2024 10:00 ET | National Association of Realtors®
Washington, D.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Key Highlights Single-family existing-home sales prices climbed in 87% of measured metro areas – 196 of 226 – in the third quarter, down...
12...292152
Next Page keyboard_arrow_right